Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

RAPT Therapeutics, Inc. (RAPT) Treasury Shares (2020 - 2023)

RAPT Therapeutics' Treasury Shares history spans 4 years, with the latest figure at $13500.0 for Q4 2023.

  • For Q4 2023, Treasury Shares fell 50.0% year-over-year to $13500.0; the TTM value through Dec 2023 reached $13500.0, down 50.0%, while the annual FY2023 figure was $13500.0, 50.0% down from the prior year.
  • Treasury Shares for Q4 2023 was $13500.0 at RAPT Therapeutics, roughly flat from $13500.0 in the prior quarter.
  • Across five years, Treasury Shares topped out at $56500.0 in Q2 2020 and bottomed at $13500.0 in Q1 2023.
  • The 4-year median for Treasury Shares is $27000.0 (2022), against an average of $32900.0.
  • The largest annual shift saw Treasury Shares fell 28.32% in 2021 before it tumbled 50.0% in 2023.
  • A 4-year view of Treasury Shares shows it stood at $56500.0 in 2020, then dropped by 28.32% to $40500.0 in 2021, then tumbled by 33.33% to $27000.0 in 2022, then crashed by 50.0% to $13500.0 in 2023.
  • Per Business Quant, the three most recent readings for RAPT's Treasury Shares are $13500.0 (Q4 2023), $13500.0 (Q3 2023), and $13500.0 (Q2 2023).